Variant report
Variant | nsv964784 |
---|---|
Chromosome Location | chr5:95940300-95945497 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:95945459..95947691-chr5:96021783..96024653,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CAST-4 | chr5:95940381-95941015 | NONHSAT102897 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78419669 | chr5:95940321-95940322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529046031 | chr5:95940405-95940406 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs12108788 | chr5:95940464-95940465 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs261213 | chr5:95940524-95940525 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs78695545 | chr5:95940527-95940528 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs371966544 | chr5:95940591-95940592 | Enhancers Weak transcription Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs17086354 | chr5:95940640-95940641 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs551790033 | chr5:95940674-95940675 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs570110415 | chr5:95940695-95940696 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs184707512 | chr5:95940708-95940709 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs543579095 | chr5:95940722-95940723 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs141729430 | chr5:95940771-95940772 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs567762242 | chr5:95940772-95940773 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs377099955 | chr5:95940795-95940796 | Enhancers Strong transcription Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs549281195 | chr5:95940805-95940806 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs534875060 | chr5:95940851-95940852 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs150650042 | chr5:95940880-95940881 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs17086358 | chr5:95940903-95940904 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs374949957 | chr5:95940908-95940909 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs545343094 | chr5:95940909-95940910 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs189789367 | chr5:95940987-95940988 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs138782770 | chr5:95940992-95940993 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs149355574 | chr5:95941024-95941025 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561600304 | chr5:95941072-95941073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116904339 | chr5:95941103-95941104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540852128 | chr5:95941177-95941178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146291549 | chr5:95941192-95941193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533072574 | chr5:95941221-95941222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369826675 | chr5:95941225-95941226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17475276 | chr5:95941265-95941266 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs571215004 | chr5:95941266-95941267 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200786408 | chr5:95941277-95941278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112641016 | chr5:95941291-95941292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537156387 | chr5:95941316-95941317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201648130 | chr5:95941345-95941346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17086361 | chr5:95941352-95941353 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs113381671 | chr5:95941353-95941354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs261212 | chr5:95941365-95941366 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs200050989 | chr5:95941384-95941385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs79229057 | chr5:95941390-95941391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181817384 | chr5:95941453-95941454 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553291247 | chr5:95941512-95941513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs261211 | chr5:95941648-95941649 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs151218762 | chr5:95941687-95941688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs538858760 | chr5:95941698-95941699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77574892 | chr5:95941746-95941747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75377966 | chr5:95941772-95941773 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542993130 | chr5:95941775-95941776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377092518 | chr5:95941835-95941836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555635435 | chr5:95941847-95941848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:95933800-95941000 | Weak transcription | Osteobl | bone |
2 | chr5:95937800-95940600 | Weak transcription | Hela-S3 | cervix |
3 | chr5:95938800-95940400 | Weak transcription | HUVEC | blood vessel |
4 | chr5:95940200-95941400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr5:95940400-95940800 | Strong transcription | HUVEC | blood vessel |
6 | chr5:95940600-95942400 | Enhancers | Hela-S3 | cervix |
7 | chr5:95940800-95943200 | Weak transcription | HUVEC | blood vessel |
8 | chr5:95941000-95941400 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr5:95941000-95941600 | Enhancers | Osteobl | bone |
10 | chr5:95941200-95942400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr5:95942400-95947800 | Weak transcription | Hela-S3 | cervix |
12 | chr5:95943200-95947000 | Strong transcription | HUVEC | blood vessel |
13 | chr5:95945000-95945400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr5:95945400-95949400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |